Study to evaluate the impact of donor-specific HLA-antibodies on graft function and survival after renal transplantation - Long term follow up of the SMART study population.
Phase of Trial: Phase IV
Latest Information Update: 15 May 2017
At a glance
- Drugs Sirolimus (Primary) ; Ciclosporin
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- 15 May 2017 New trial record